TABLE 2.

Proportion of patients with clinical levels of symptoms at baseline.

Variable	MAG‐EPA (n = 65; %)	Placebo (n = 65; %)
HADS‐D (≥7)	9.5	13.9
PHQ‐9 (≥10)	6.3	1.5
HADS‐A (≥7)	25.0	36.5
FCRI‐Severity (≥13)	32.3	53.1
ISI (≥8)	34.4	43.8
FSI‐Severity (≥3)	44.4	48.4
FACT‐COG‐PCI (<54)	22.2	12.9

Abbreviations: FACT‐Cog, Functional Assessment of Cancer Therapy—Cognitive Function; FCRI, Fear of Cancer Recurrence Inventory; FSI, Fatigue Symptom Inventory; HADS‐A, anxiety subscale of the Hospital Anxiety and Depression Scale; HADS‐D, depression subscale of the Hospital Anxiety and Depression Scale; ISI, Insomnia Severity Index; MAG‐EPA, monoacylglyceride‐conjugated eicosapentaenoic acid; PCI, perceived cognitive impairment; PHQ‐9, Patient Health Questionnaire‐9.